Skandinaviska Enskilda Banken (SEB)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.7K | Sell |
|
|||||
|
2025
Q2 | $21.8K | Hold |
|
|||||
|
2025
Q1 | $21.7K | Sell |
|
|||||
|
2024
Q4 | $1.7M | Hold |
|
|||||
|
2024
Q3 | $1.83M | Sell |
|
|||||
|
2024
Q2 | $15.2M | Sell |
|
|||||
|
2024
Q1 | $30.1M | Sell |
|
|||||
|
2023
Q4 | $26.3M | Hold |
|
|||||
|
2023
Q3 | $21.8M | Sell |
|
|||||
|
2023
Q2 | $23.4M | Sell |
|
|||||
|
2023
Q1 | $23M | Sell |
|
|||||
|
2022
Q4 | $25M | Buy |
|
|||||
|
2022
Q3 | $22.5M | Buy |
|
|||||
|
2022
Q2 | $20.2M | Buy |
|
|||||
|
2022
Q1 | $22.9M | Buy |
|
|||||
|
2021
Q4 | $26.5M | Sell |
|
|||||
|
2021
Q3 | $32.2M | Buy |
|
|||||
|
2021
Q2 | $4.96M | Buy |
|
|||||
|
2021
Q1 | $1.6M | Buy |
|
|||||
|
2020
Q4 | $1.29M | Sell |
|
|||||
|
2020
Q3 | $1.23M | Buy |
|
|||||
|
2020
Q2 | $21K | Buy |
|